Acquisition Avalon Capital Startup 
socalTECH
JULY 16, 2013
In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. core innovation capital venture investment fund' The firm''s efforts here are headed by Arjun Schutte. READ MORE>>.
socalTECH
JUNE 11, 2021
La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company's biggest shareholders before the IPO were Avalon Ventures, RA Capital Healthcare, Orbimed, Bregua Corporation, and Correlation Ventures.
Xconomy
SEPTEMBER 11, 2019
GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.
Expert insights. Personalized for you.
174 
Let's personalize your content